Method for detection of simian immunodeficiency virus neutralizing antibodies using a noncommercial antigen capture...

Area of Science:

• Virology
• Immunology
• Primate Models

Background:

• Simian immunodeficiency virus (SIV) infection in macaques serves as a model for human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS).
• Understanding the role of neutralizing antibodies in SIV infection is crucial for vaccine development and therapeutic strategies.
• Existing methods for detecting SIV neutralizing antibodies can be complex or costly.

Purpose of the Study:

• To develop and validate a simple, cost-effective neutralization test (NT) for detecting SIV growth in vitro.
• To assess the utility of this NT for measuring neutralizing antibodies in experimentally infected macaques.

Main Methods:

• Development of a noncommercial antigen capture enzyme-linked immunosorbent assay (ELISA) for SIV detection.
• Utilized a mixture of purified macaque anti-SIV immunoglobulin G (IgG) and a monoclonal antibody to SIV p27 as capture antibodies.
• Detected captured SIV antigens using macaque anti-SIV IgG conjugated to horseradish peroxidase.
• Tested sequential sera from an experimentally SIV-infected macaque against SIV using the developed NT.

Main Results:

• The NT reliably and sensitively detected differences in SIV growth with varying SIV amounts and control sera.
• Neutralizing activity and anti-SIV IgG levels in the infected macaque serum increased over time post-inoculation.
• High IgG titers were necessary for effective in vitro neutralization of SIV.
• The NT demonstrated a low cost and high sensitivity for detecting SIV neutralizing antibodies.

Conclusions:

• A simple, sensitive, and low-cost NT for detecting SIV neutralizing antibodies has been successfully developed.
• This NT is suitable for use with the SIV-infected macaque model, aiding in the study of neutralizing antibody responses.
• The findings highlight the correlation between IgG antibody levels and neutralizing activity, providing insights into SIV pathogenesis and potential interventions.